Love watching and reading the conspiracy theories abounding. Pump and dump for cap raising, SRX takeover etc etc. OSL is just cheap in my thinking. The Company now has 4 ex-SRX execs in the business (small aps are far more fun to work for as you can shape the business, with SRX the horse has bolted), the Company still only has a mkt cap of ~$70m and is led by a big pharma team. Look at a lot of the biotech rubbish floated with mkt caps of $150m, with average management. This one is on the cusp of CE marks, an agreed IDE / FDA trial and will have revenues in 2016. SRX was $200m when it got its CE mark. At $200m, this is trading at $0.57. History does repeat, we just don't learn from it. The pop should be harder as under owned by institutions. Stay long and strong and surprise thyself!!!
Disclaimer: Very long and content!
OSL Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)